phase II clinical study
BlackfinBio Launching Gene Therapy Trial in Rare Neurological Condition at Boston Children's
The UK-based company will evaluate BFB-101 in up to five children with hereditary spastic paraplegia type 47 in a Phase I/II trial.
March Biosciences Begins Dosing Lymphoma Patients With Cell Therapy in Phase II Trial
The trial will test MB-105 in up to 46 patients with relapsed or refractory CD5-positive cutaneous T-cell lymphoma or peripheral T-cell lymphoma.
Cardiff Oncology Completes Enrollment in Onvansertib Study in First-Line RAS-Mutant Colorectal Cancer
The firm is comparing onvansertib plus standard chemo and Avastin against the standard-of-care regimen alone.
NHS England Partners With Scancell to Expand Cancer Vaccine Trial in Melanoma
In the trial, researchers are evaluating Scancell's DNA cancer vaccines SCIB1 and iSCIB1+ alongside immunotherapy.
Verve Advances Clinical Development Plans for Base-Editing Heart Disease Treatment
After VERVE-102 showed the ability to lower LDL-C and PCSK9 in the Heart-2 trial, the firm said it will advance the therapy to a Phase II study later this year.
Mar 28, 2025